195.96
+5.73(+3.01%)
Currency In USD
| Previous Close | 190.23 |
| Open | 190.36 |
| Day High | 196.78 |
| Day Low | 188.19 |
| 52-Week High | 207.84 |
| 52-Week Low | 122.8 |
| Volume | 286,578 |
| Average Volume | 351,351 |
| Market Cap | 5.67B |
| PE | 39.75 |
| EPS | 4.93 |
| Moving Average 50 Days | 160.52 |
| Moving Average 200 Days | 156.73 |
| Change | 5.73 |
If you invested $1000 in Krystal Biotech, Inc. (KRYS) since IPO date, it would be worth $18,417.29 as of October 20, 2025 at a share price of $195.96. Whereas If you bought $1000 worth of Krystal Biotech, Inc. (KRYS) shares 5 years ago, it would be worth $4,202.44 as of October 20, 2025 at a share price of $195.96.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
GlobeNewswire Inc.
Oct 14, 2025 12:00 PM GMT
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology designation to the genetically modified, non-re
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
GlobeNewswire Inc.
Sep 15, 2025 12:00 PM GMT
Revised label allows treatment of DEB patients from birth VYJUVEK can now be applied by patients and caregivers PITTSBURGH, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United Sta
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
GlobeNewswire Inc.
Sep 02, 2025 12:00 PM GMT
PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishn